Shaping the Future: GCC Oncology/Cancer Drugs Market Trends and Forecasts for 2028

GCC Oncology/Cancer Drugs Market Ov erview:

According to MarkNtel Advisors study the GCC Oncology/Cancer Drugs Market is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. This is due to the rising incidences of patients diagnosed with cancer in the nations like the UAE, Saudi Arabia, Kuwait, etc., and the surging initiative to reduce the number of deaths due to cancer. As per the World Health Organization, a total of around 21.4% of breast cancer cases were reported in 2020 in the UAE, whereas the same around 14.5% of colorectal cancer, and nearly 12.5% of prostate cancer were reported among men in the country.

Key Findings of the Study: GCC Oncology/Cancer Drugs market

Key Driver: Growing Prevalence of Various Cancer Cases to Uplift the Oncology/Cancer Drugs Market

The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% male of Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period.

In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.

Scope of the GCC Oncology/Cancer Drugs Market Report Segmentation

-By Therapy

Chemotherapy
Immunotherapy
Targeted Therapy
Hormonal Therapy
Others

-By Application

Breast Cancer
Lung Cancer
Kidney Cancer
Liver cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Pancreatic Cancer
Colorectal
Blood Cancer
Others

For more detailed information about the GCC Oncology/Cancer Drugs market report, click here – https://www.marknteladvisors.com/research-library/gcc-oncology-cancer-drugs-market.html

Geographical analysis:

-By Country

Saudi Arabia
The UAE
Qatar
Kuwait
Bahrain
Oman

Among all the nations, the UAE is expected to be a hotspot for the demand for oncology/cancer drugs in the forecast years, owing to the massive surge in the cases of breast cancer among the female population of the country. In addition, the malignancy of breast cancer cases in the UAE has led to the launch of several awareness campaigns for the detection of breast cancer among the female population. For instance, in 2022, Sheikh Shakhbout Medical City (SSMC) in Abu Dhabi launched a new support group for breast cancer patients as part of its awareness campaign to combat the disease. Furthermore, the growing focus of the UAE government to amplify medical tourism in the country is also predicted to accelerate the growth of the GCC Oncology/Cancer Drugs market from 2023 to 2028.

Current Landscape of GCC Oncology/Cancer Drugs Market

The report delineates key market participants and thoroughly assesses their strategic approaches, trends, innovations, and manufacturing infrastructure, enabling a forecast of their market impact over the next five years. The meticulously researched data presented holds the potential to distinguish even nascent market entrants in the long term. Armed with pertinent data and actionable insights, our research report delivers a comprehensive overview of the market, empowering investors and stakeholders to establish a robust presence in the GCC Oncology/Cancer Drugs market. The research report profiles major players, including

Customization of Reports Available - https://www.marknteladvisors.com/query/request-customization/gcc-oncology-cancer-drugs-market.html

Hoffmann-La Roche Ltd.
Johnson Johnson Middle East FZ LLC
Pfizer International Corporation
Merck Serono Middle East FZ-Ltd.
AbbVie Biopharmaceuticals GmbH
AstraZeneca Gulf FZ LLC
Bayer Middle East FZE
Amgen, Inc.
Astellas MENA/SSA
Others

Related Reports

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 14.8 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India